151 related articles for article (PubMed ID: 11603279)
1. Endocannabinoid immune and vascular signaling.
Stefano GB
Acta Pharmacol Sin; 2000 Dec; 21(12):1071-81. PubMed ID: 11603279
[No Abstract] [Full Text] [Related]
2. The quest for a vascular endothelial cannabinoid receptor.
Kunos G; Bátkai S; Offertáler L; Mo F; Liu J; Karcher J; Harvey-White J
Chem Phys Lipids; 2002 Dec; 121(1-2):45-56. PubMed ID: 12505689
[TBL] [Abstract][Full Text] [Related]
3. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
Mechoulam R
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids and vascular function.
Hillard CJ
J Pharmacol Exp Ther; 2000 Jul; 294(1):27-32. PubMed ID: 10871291
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids and the gut.
Pinto L; Capasso R; Di Carlo G; Izzo AA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids: a new class of vasoactive substances.
Randall MD; Kendall DA
Trends Pharmacol Sci; 1998 Feb; 19(2):55-8. PubMed ID: 9550942
[TBL] [Abstract][Full Text] [Related]
7. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
9. Retrograde signaling by endocannabinoids.
Kreitzer AC; Regehr WG
Curr Opin Neurobiol; 2002 Jun; 12(3):324-30. PubMed ID: 12049940
[TBL] [Abstract][Full Text] [Related]
10. Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity.
Prieto D
Eur Urol; 2010 Feb; 57(2):349. PubMed ID: 19147273
[No Abstract] [Full Text] [Related]
11. Comparative biology of the endocannabinoid system possible role in the immune response.
Salzet M; Breton C; Bisogno T; Di Marzo V
Eur J Biochem; 2000 Aug; 267(16):4917-27. PubMed ID: 10931174
[TBL] [Abstract][Full Text] [Related]
12. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
Schmid HH; Schmid PC; Berdyshev EV
Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids: new targets for drug development.
Di Marzo ; Bisogno T; De Petrocellis L
Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
15. Endogenous cannabinoid signaling.
Piomelli D; Beltramo M; Giuffrida A; Stella N
Neurobiol Dis; 1998 Dec; 5(6 Pt B):462-73. PubMed ID: 9974178
[No Abstract] [Full Text] [Related]
16. Discovery and isolation of anandamide and other endocannabinoids.
Hanus LO
Chem Biodivers; 2007 Aug; 4(8):1828-41. PubMed ID: 17712821
[No Abstract] [Full Text] [Related]
17. The endocannabinoid system as a target for therapeutic drugs.
Piomelli D; Giuffrida A; Calignano A; Rodríguez de Fonseca F
Trends Pharmacol Sci; 2000 Jun; 21(6):218-24. PubMed ID: 10838609
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids.
Mechoulam R; Fride E; Di Marzo V
Eur J Pharmacol; 1998 Oct; 359(1):1-18. PubMed ID: 9831287
[TBL] [Abstract][Full Text] [Related]
19. 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1.
Stefano GB; Bilfinger TV; Rialas CM; Deutsch DG
Pharmacol Res; 2000 Oct; 42(4):317-22. PubMed ID: 10987990
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids in the central nervous system--an overview.
Fride E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
